Maynard Um
-
-
-
-
-
-
-
Allurion reports Q4 revenue growth of up to 37% quarter-over-quarter
-
-
-
-
-
-
-
Allurion shifts strategy to focus on GLP-1 combination therapy
-
-
-
-
-
-
-
Chardan Capital Markets Reiterates Neutral Rating on Allurion Technologies (ALUR)
-
-
-
-
-
-
-
Allurion Technologies (ALUR) Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
-
-
-
-
-
-
-
Allurion Technologies (ALUR) Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference
-
-
-
-
-
-
-
Allurion Technologies (ALUR) Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors
-
-
-
-
-
-
412,928 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

